Uterin fibroidler ve güncel klinik tarti{dotless}şmalar

Translated title of the contribution: Uterine fibroids and current clinical challenges

Salama S. Salama, Gokhan Kilic

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Uterine fibroids (UF) are the most common gynecological tumors in premenopausal women. Hysterectomy remains the major and definitive therapeutic option. Minimally invasive surgical techniques for performing hysterectomy have many advantages over laparotomy. Current drug therapies for UF remain unsatisfactory. Unquestionably, continued investigation of novel agents is necessary. The currently used drugs for UF treatment which exclusively modulate a single target, typically either the estrogen or progesterone signaling pathways, are limited in their therapeutic effects. By contrast, multi-target drugs which simultaneously modulate multiple critical hubs in the network of the signaling pathways underlying UF pathogenesis should achieve robust and durable therapeutic effects.

Original languageUndefined
Pages (from-to)40-45
Number of pages6
JournalJournal of the Turkish German Gynecology Association
Volume14
Issue number1
DOIs
StatePublished - 2013

Fingerprint

Leiomyoma
Therapeutic Uses
Hysterectomy
Pharmaceutical Preparations
Laparotomy
Progesterone
Estrogens
Drug Therapy
Therapeutics
Neoplasms

Keywords

  • Drug therapy
  • Hysterectomy
  • Multi-target drugs
  • Pathogenesis
  • Uterine fibroids

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Uterin fibroidler ve güncel klinik tarti{dotless}şmalar. / Salama, Salama S.; Kilic, Gokhan.

In: Journal of the Turkish German Gynecology Association, Vol. 14, No. 1, 2013, p. 40-45.

Research output: Contribution to journalArticle

@article{a157ee617ddb4aac8cff68ad20e5a5e6,
title = "Uterin fibroidler ve g{\"u}ncel klinik tarti{dotless}şmalar",
abstract = "Uterine fibroids (UF) are the most common gynecological tumors in premenopausal women. Hysterectomy remains the major and definitive therapeutic option. Minimally invasive surgical techniques for performing hysterectomy have many advantages over laparotomy. Current drug therapies for UF remain unsatisfactory. Unquestionably, continued investigation of novel agents is necessary. The currently used drugs for UF treatment which exclusively modulate a single target, typically either the estrogen or progesterone signaling pathways, are limited in their therapeutic effects. By contrast, multi-target drugs which simultaneously modulate multiple critical hubs in the network of the signaling pathways underlying UF pathogenesis should achieve robust and durable therapeutic effects.",
keywords = "Drug therapy, Hysterectomy, Multi-target drugs, Pathogenesis, Uterine fibroids",
author = "Salama, {Salama S.} and Gokhan Kilic",
year = "2013",
doi = "10.5152/jtgga.2013.09",
language = "Undefined",
volume = "14",
pages = "40--45",
journal = "Journal of the Turkish German Gynecology Association",
issn = "1309-0399",
publisher = "Aves",
number = "1",

}

TY - JOUR

T1 - Uterin fibroidler ve güncel klinik tarti{dotless}şmalar

AU - Salama, Salama S.

AU - Kilic, Gokhan

PY - 2013

Y1 - 2013

N2 - Uterine fibroids (UF) are the most common gynecological tumors in premenopausal women. Hysterectomy remains the major and definitive therapeutic option. Minimally invasive surgical techniques for performing hysterectomy have many advantages over laparotomy. Current drug therapies for UF remain unsatisfactory. Unquestionably, continued investigation of novel agents is necessary. The currently used drugs for UF treatment which exclusively modulate a single target, typically either the estrogen or progesterone signaling pathways, are limited in their therapeutic effects. By contrast, multi-target drugs which simultaneously modulate multiple critical hubs in the network of the signaling pathways underlying UF pathogenesis should achieve robust and durable therapeutic effects.

AB - Uterine fibroids (UF) are the most common gynecological tumors in premenopausal women. Hysterectomy remains the major and definitive therapeutic option. Minimally invasive surgical techniques for performing hysterectomy have many advantages over laparotomy. Current drug therapies for UF remain unsatisfactory. Unquestionably, continued investigation of novel agents is necessary. The currently used drugs for UF treatment which exclusively modulate a single target, typically either the estrogen or progesterone signaling pathways, are limited in their therapeutic effects. By contrast, multi-target drugs which simultaneously modulate multiple critical hubs in the network of the signaling pathways underlying UF pathogenesis should achieve robust and durable therapeutic effects.

KW - Drug therapy

KW - Hysterectomy

KW - Multi-target drugs

KW - Pathogenesis

KW - Uterine fibroids

UR - http://www.scopus.com/inward/record.url?scp=84875860995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875860995&partnerID=8YFLogxK

U2 - 10.5152/jtgga.2013.09

DO - 10.5152/jtgga.2013.09

M3 - Article

VL - 14

SP - 40

EP - 45

JO - Journal of the Turkish German Gynecology Association

JF - Journal of the Turkish German Gynecology Association

SN - 1309-0399

IS - 1

ER -